Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=06b84639-49e9-43f4-94ab-d8c369e0e924
Date 9/9/2016
Company Name AnTolRx
Mailing Address Building 1400 West Cambridge, MA 02139 USA
Company Description At AnTolRx we are approaching the treatment of autoimmune diseases differently–through the development of novel nanoparticle-based therapies to promote antigen-specific immune tolerance. Standard therapies broadly suppress the immune system, inducing side effects that may include life threatening infections and tumors.
Proceeds Purposes We are grateful for the funding and support we have received from Pfizer, JDRF and Orion, as we continue to focus on developing disease-modifying therapies for patients with immune disorders, including type 1 diabetes, multiple sclerosis and inflammatory bowel disease.